Chatterjee G, Dhende P, Raj S, Shetty V, et al. 15-color highly sensitive flow cytometry assay for post anti-CD19 targeted therapy (anti-CD19-CAR-T and blinatumomab) measurable residual disease assessment in B-lymphoblastic leukemia/lymphoma: Real-world applicability and challenges. Eur J Haematol 2023 Sep 14. doi: 10.1111/ejh.14102.
PMID: 37706583